Clinical trials
Heart Failure Patients clinical trials
Below are recruiting heart failure patients clinical trials, each written for real people, not researchers. We’re tracking 796 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06714409Recruiting
Ultrasound-guided fluid removal in hospitalized heart failure
This study tests whether using ultrasound-guided treatment to reduce fluid buildup in the body can help people hospitalized for worsening heart failure feel better faster. It's for adults admitted with heart failure and high BNP levels.
OsloAges 18 years+ - NCT06724653Recruiting
Reducing Heart Failure Meds After Heart Recovery Study
This trial tests whether it is safe to slowly reduce some heart failure medications for people whose heart function has improved to normal. It is for patients who once had a weak heart pump but now have recovered strength and are stable on multiple medicines.
Jeonju, Jeollabuk-doAges 18 years+ - NCT06734065Recruiting
Heart failure monitoring with a non-invasive lung fluid sensor
This trial tests a new device that measures fluid in your lungs without needles or surgery. It may help your doctor manage heart failure better, especially if you've been in the hospital recently or have symptoms like shortness of breath.
FlenAges 18 years+ - NCT06737679Recruiting
Body scan therapy for heart failure patients
This trial tests whether a guided body scan can help people with heart failure better recognize their body's internal signals. It may improve how you understand and manage your symptoms.
Milan, ItalyAges 18–75 - NCT06747689Recruiting
Sleep quality and self-care in heart failure
This study looks at how sleep quality affects the ability of people with heart failure to manage their own health. It aims to find if better sleep leads to better self-care.
IzmirAges 18 years+ - NCT06758128Recruiting
Genes and immunity in worsening heart failure
This study looks at how your genes and immune system affect heart failure. Researchers want to understand why some people have flare-ups (exacerbations) and how the body responds.
San Giovanni Rotondo, FoggiaAges 18 years+ - NCT06774014Recruiting
Heart failure and diabetes: cell study
This study looks at how cells talk to each other in people who have both diabetes and heart failure. It may help doctors understand these conditions better.
Leeds, West YorkshireAges 18 years+ - NCT06783335Recruiting
Cordella sensor for chronic heart failure
This trial studies a small sensor placed in the lung artery to help manage chronic heart failure. It compares patients who get the sensor to those who receive standard care, to see if the sensor improves outcomes.
Naperville, IllinoisAges 18 years+ - NCT06800716Recruiting
Impella temporary pump for end-stage heart failure
This study tests whether using a temporary heart pump called Impella 5.5 can help strengthen a very weak and enlarged heart (dilated cardiomyopathy) in people who are waiting for a heart transplant. If you qualify, the pump is placed to support your heart temporarily, and the research team will check how your heart responds.
New York, New YorkAges 18 years+ - NCT06809686Recruiting
ECG and patient experience study for heart failure
This study collects detailed ECG data and feedback from people with heart failure to better understand the condition and improve care. It involves noninvasive monitoring and a discussion of your symptoms and daily life.
London, LondonAges 45–80 - NCT06826963Recruiting
Eccentric exercise for older adults with heart failure and muscle loss
This study tests whether a special type of exercise (eccentric, or lengthening, exercises) can help older adults with heart failure who also have muscle loss. It aims to see if the exercise is safe and improves strength and function.
Verona, VeronaAges 65–85 - NCT06851949RecruitingPhase 2
Vsling device for ventricular repair in heart failure
This trial tests a new device called Vsling, which is placed inside the heart to help reshape the main pumping chamber (left ventricle) in people with heart failure. It may improve your heart's strength and reduce symptoms like shortness of breath.
Be’er Ya‘aqovAges 18 years+ - NCT06868797Recruiting
Dapagliflozin for advanced heart failure patients waiting for transplant
This study tests whether dapagliflozin (a medicine already approved for other heart conditions) can help protect kidney and heart function in people with very advanced heart failure who are waiting for a heart transplant. If you qualify, you'll help researchers learn if this drug offers extra benefits beyond standard care.
BronAges 18 years+ - NCT06884631Recruiting
Heart failure risk assessment with exercise test and kidney health
This study uses a special exercise test, along with heart and kidney measurements, to better predict risks for people with heart failure. It may help your doctors understand your condition and choose the best care for you.
Milan, ItalyAges 18 years+ - NCT06885164Recruiting
Remote heart monitoring for heart failure patients
This trial tests whether remote monitoring of heart function can help manage heart failure. It may be an option if you have symptoms like shortness of breath or fatigue (NYHA class II or higher) and are between 18 and 90 years old.
Aalborg, DenmarkAges 18–90 - NCT06920160Recruiting
Remote monitoring for heart failure with reduced ejection fraction
This trial tests whether a smartphone app can help monitor your heart health after a hospital stay for heart failure. It is for people who use a smartphone often and have a type of heart failure where the heart's pumping strength is lower than normal.
Ferrol, A CoruñaAges 18 years+ - NCT06961929Recruiting
Heat and Heart Failure Study
This study looks at how heat affects the body in people with stable heart failure compared to healthy volunteers. It may help researchers understand how to better manage heart failure in daily life.
Dallas, TexasAges 45 years+ - NCT06964464RecruitingPhase 4
Comparing two heart failure medications in ICD patients
This trial compares two beta-blocker medications, carvedilol and metoprolol succinate, to see which one works better for people with heart failure who have an implantable cardioverter defibrillator (ICD). If you are currently taking metoprolol succinate, you may be able to switch to carvedilol and help researchers find the best treatment.
Scottsdale, ArizonaAges 18 years+ - NCT06969560Recruiting
Wearable monitor for heart failure in kids
This study tests a wearable patch (like a smart bandage) that tracks your heart health at home. It's for children and teens with heart failure to help doctors monitor them without frequent hospital visits.
Edmonton, AlbertaAges 8–18 - NCT06989580Recruiting
Heart failure monitoring with a wireless implant
This trial is testing a special monitor (BIOMONITOR) that tracks your heart function and sends data wirelessly to your doctor. It aims to help manage heart failure by catching early signs of trouble so you can get treatment sooner.
GenkAges 18 years+ - NCT06993220Recruiting
Reducing fluid buildup in heart failure patients at discharge
This trial is for people hospitalized with heart failure and signs of fluid overload, such as swelling or fluid in the lungs. It aims to check if patients still have extra fluid when they go home, which may help improve their recovery.
Sant Joan Despí, BarcelonaAges 18 years+ - NCT07008365RecruitingPhase 3
Measuring belly pressure and ultrasound to guide fluid removal in heart failure
This trial tests whether using belly pressure and bedside ultrasound can help doctors better manage fluid removal (decongestion) in people hospitalized with heart failure. The goal is to see if this approach leads to better outcomes.
ZaragozaAges 18–100 - NCT07023536Recruiting
Heart rehab program from home for chronic heart failure
This trial tests a cardiac telerehabilitation program for people with chronic heart failure. It is designed to see if doing rehab at home using digital tools helps improve health and quality of life.
SalernoAges 18 years+ - NCT07047547Recruiting
Vericiguat study for kidney disease and heart failure patients
This trial tests how a medication called vericiguat works in people with both chronic kidney disease and heart failure. It aims to see if the drug helps manage these conditions together.
Guangzhou, GuangdongAges 18–80
Hear when a new Heart Failure Patients trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for heart failure patients?
- Yes. Clin2 currently lists 796 recruiting heart failure patients studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a heart failure patients trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a heart failure patients trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.